Synonyms:Prostaglandin E2, Dinoprostone, PGE2, 363-24-6, Prostin E2, Prepidil, Cervidil, Propess, Minprositin E2, Minprostin E2, Dinoproston, Prostin, (15S)-Prostaglandin E2, Prostarmon E, Dinoprostonum, l-Prostaglandin E2, Dinoprostona, Glandin, l-PGE2, (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, U-12062, (-)-Prostaglandin E2, Prostaglandin E, UNII-K7Q1JQR04M, (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid, NSC 165560, [3H]PGE2, U 12062, [3H]prostaglandin E2, (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid, (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid, CHEMBL548, NSC 196514, K7Q1JQR04M, 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid, l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate, CHEBI:15551, (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate, 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-, PGE2alpha, Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-, MFCD00077861, Prostaglandin E(2), NSC-165560, NSC-196514, (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid, NCGC00092361-05, Prostaglandin E2alpha, Prostaglandin E2.alpha., (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, DSSTox_CID_2947, 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, DSSTox_RID_76801, DSSTox_GSID_22947, Dinoprostonum [INN-Latin], U-12,062, 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid, Dinoprostona [INN-Spanish], Cerviprime, Prostenone, Enzaprost E, 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid, Prostarmon E2, Cervidil (TN), Prepidil (TN), CAS-363-24-6, Dinoprostone Prostaglandin E2, U,062, Prostin E2 (TN), PGE2-[3,3,4,4-d4], SR-05000001459, EINECS 206-656-6, Dinoprostone (JAN/USP/INN), (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, BML1-F07, Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-, Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-, Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-, [3H]dinoprostone, 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-, prosta-glandin e2, NCGC00092361-06, (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid, P2E, Prestwick_793, (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, [3H]prostin E2, BMS-279654 & PGE2, Dinoprostone beta-Cyclodextrin Clathrate, Dinoprostone [USAN:USP:INN:BAN:JAN], (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic, Prostaglandin E2 (PGE2), SCHEMBL25533, BSPBio_001490, GTPL1883, GTPL1916, DTXSID4022947, [3H]-PGE2, BDBM35847
Id:5280360
Description:nan